Furthermore, a recent study reported that hepcidin therapy reduces iron accumulation in the kidney and alleviates the disease progression of lupus nephritis in MRL/lpr lupus-prone mice (19), suggesting that modulating iron homeostasis may be a promising therapeutic strategy for lupus nephritis. This evidence concerns the gene HAMP and lupus nephritis.